Small Molecules, Custom Pharma Services
Total Trials
240
As Lead Sponsor
226
As Collaborator
14
Total Enrollment
47,185
NCT00404989
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
Phase: N/A
Role: Collaborator
Start: Jan 31, 1989
Completion: Jan 31, 2099
NCT01511731
Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 1998
Completion: Oct 31, 1998
NCT01888328
Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed Condition
Start: May 31, 2001
Completion: Jun 30, 2001
NCT01888289
Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting Condition
Start: Jul 31, 2001
Completion: Sep 30, 2001
NCT01065987
Bioequivalence Study of Tizanidine HCl 4mg Tablets of Dr.Reddy's Under Fed Conditions
Start: Sep 30, 2001
Completion: Nov 30, 2001
NCT01146028
Bioequivalence Study of Tizanidine HCl Tablets 4 mg of Dr.Reddys Under Fasting Conditions
NCT01286688
Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fasting Conditions
Start: Jan 31, 2002
Completion: Mar 31, 2002
NCT01286701
Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed Conditions
NCT01066754
Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions
Start: Apr 30, 2002
Completion: May 31, 2002
NCT01066767
Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed Conditions
NCT01133444
Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition
NCT01133457
Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition
NCT01064154
Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fasting Conditions
Start: May 31, 2002
NCT01064180
Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fed Conditions
NCT01511757
Bioavailability Study of Fluconazole Tablets 200 mg Under Fed Conditions
Start: Jun 30, 2002
Completion: Jul 31, 2002
NCT01131936
Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fed Conditions
Start: Aug 31, 2002
Completion: Nov 30, 2002
NCT01511770
Bioavailability Study of Fluconazole Tablets 200 mg Under Fasting Conditions
Completion: Sep 30, 2002
NCT01888341
Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition
Completion: Aug 31, 2002
NCT01131923
Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fasting Conditions
Start: Oct 31, 2002
Completion: Dec 31, 2002
NCT01146093
Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fed Conditions
Start: Nov 30, 2002
Completion: Mar 31, 2003
NCT01149941
Bioequivalence Study of Ibuprofen 200 mg Gel Capsules of Dr. Reddy's Laboratories Under Fasting Condition
NCT01513681
Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition
NCT01146106
Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditions
Start: Dec 31, 2002
NCT01513720
Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition
NCT01131702
Bioequivalency Study of Ranitidine Tablets 300 mg of Dr. Reddy's Under Fasting Conditions
Start: Jan 31, 2003
NCT01131949
Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fasting Condition
NCT01131975
Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fed Condition
NCT01149954
Bioequivalence Study of Ibuprofen 200 mg Soft Gel Capsules of Dr. Reddy's Laboratories Limited Under Fed Conditions
Completion: Jan 31, 2003
NCT01131897
Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions.
Start: Sep 30, 2003
Completion: Nov 30, 2003
NCT01132352
Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions
NCT01149967
Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
Start: Oct 31, 2003
NCT01149980
Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions
NCT01052909
Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting Condition
Start: Dec 31, 2003
Completion: Dec 31, 2003
NCT01053689
Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed Condition
NCT01146067
Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions
Start: Jan 31, 2004
Completion: Feb 29, 2004
NCT01146041
Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions
Start: Feb 29, 2004
Completion: Apr 30, 2004
NCT01155895
Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions
Start: Mar 31, 2004
NCT01131728
Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fasting Conditions
Start: Jul 31, 2004
Completion: Sep 30, 2004
NCT01131767
Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fed Conditions
NCT01161927
Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Non- Fasting Conditions
NCT01161940
Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
NCT01155921
Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
Start: Aug 31, 2004
Completion: Aug 31, 2004
NCT01155934
Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions
NCT01132222
Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Under Fed Conditions
Start: Sep 30, 2004
Completion: Oct 31, 2004
NCT01161134
Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition
Completion: Nov 30, 2004
NCT01131780
Bioequivalency Study of Ibuprofen 200 mg and Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's Under Fasting Conditions
Start: Oct 31, 2004
NCT01160029
Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed Condition
NCT01161147
Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition
Completion: Dec 31, 2004
NCT01283919
Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition
NCT01283932
Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed Condition
NCT01372280
Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition
NCT01372306
Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition
NCT01581866
Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions
Start: Nov 30, 2004
Completion: Jan 31, 2005
NCT01581879
Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions
NCT01160042
Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting Condition
Start: Jan 31, 2005
Completion: Apr 30, 2005
NCT01161966
Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
Completion: Mar 31, 2005
NCT01161979
Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions
NCT01167894
Bioequivalence Study of Simvastatin Tablets 80 mg of Dr. Reddy's Under Fasting Condition
NCT01167933
Bioequivalence Study of Simvastatin Tablets, 80 mg of Dr. Reddy's Under Fed Conditions
NCT01372358
Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions
Completion: Feb 28, 2005
NCT01160068
Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fed Condition
Start: Feb 28, 2005
Completion: May 31, 2005
NCT01372345
Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions
NCT01155908
Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions
Start: Apr 30, 2005
NCT01269281
Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions
Start: Jul 31, 2005
Completion: Jul 31, 2005
NCT01164761
Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions
Start: Sep 30, 2005
Completion: Oct 31, 2005
NCT01164774
Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions
Start: Oct 31, 2005
Completion: Nov 30, 2005
NCT01314339
Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.
Start: Dec 31, 2005
Completion: Feb 28, 2006
NCT01314352
Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions
Completion: Mar 31, 2006
NCT01064102
Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition
Start: Jan 31, 2006
NCT01064115
Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition
NCT01170169
Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting Conditions
NCT01506037
Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed Condition
NCT01506050
Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition
NCT01166087
Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed Condition
Start: Feb 28, 2006
Completion: Sep 30, 2006
NCT01166100
Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition
Completion: Aug 31, 2006
NCT01170182
Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition
Completion: Apr 30, 2006
NCT01164787
Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting Conditions
Start: Mar 31, 2006
Completion: May 31, 2006
NCT01164800
Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed Conditions
NCT01164813
Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fasting Conditions
NCT01164826
Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fed Conditions
NCT01373138
Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting Conditions
Start: Apr 30, 2006
NCT01506791
Bioequivalence Study of Desloratadine and Pseudoephedrine Extended-release Tablets Under Fed Conditions
NCT01052129
Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition
Start: May 31, 2006
NCT01052792
Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fed Conditions
Completion: Jun 30, 2006
NCT01512459
Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions
NCT01132040
Bioequivalence Study of Primidone Tablets 50 mg of Dr. Reddy's Under Fasting Conditions
Start: Aug 31, 2006
NCT01132170
Bioequivalency Study of Divalproex Sodium DR Tablets, 500 mg of Dr.Reddy's Under Fasting Conditions
Completion: Nov 30, 2006
NCT01132196
Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Under Fed Conditions
NCT01267383
Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg in Fed Conditions
Start: Sep 30, 2006
Completion: Oct 31, 2006
NCT01267396
Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg Under Fasting Conditions
NCT01506713
Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions
NCT01064232
Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition
Start: Oct 31, 2006
NCT01064271
Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition
NCT01511705
Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting Condition
NCT01511718
Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed Condition
NCT01512485
Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed Conditions
NCT01264289
Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Conditions
Start: Nov 30, 2006
NCT01264302
Bioequivalence Study of Two Finasteride 5 mg Tablet Formulations Under Non-Fasting Conditions
NCT01503437
Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition
Completion: Dec 31, 2006
NCT01503450
Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition
NCT01045434
Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed Conditions
Start: Dec 31, 2006
Completion: Mar 31, 2007
NCT01045642
Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsules Under Fasting Conditions
NCT01055938
Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 mg Under Fasting Conditions
NCT01056627
Bioequivalence Study of Dr. Reddy's Divalproex Sodium Coated Particles in Capsules, 125 mg, Under Fed Condition
NCT01133496
Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions
Completion: Apr 30, 2007
NCT01132183
Bioequivalence Study of Divalproex Sodium Capsules(Sprinkle),125 mg of Dr. Reddy's Under Fasting Condition (Apple Sauce)
Start: Feb 28, 2007
NCT01133470
Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr. Reddy's and Allegra D 24 Hour ER Tablets Under Fasting Conditions
NCT01136525
Bioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fasting Conditions
Completion: May 31, 2007
NCT01136538
Bioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fed Condition
NCT01159158
Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition
Completion: Feb 28, 2007
NCT01505998
Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions
Start: Mar 31, 2007
NCT01506011
Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions
NCT01133483
Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr.Reddy's Under Fed Conditions
Start: Apr 30, 2007
NCT01283841
Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Fasting Conditions
Start: Nov 30, 2007
Completion: Dec 31, 2007
NCT01283867
Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Non-Fasting Conditions
NCT01283061
Bioequivalence Study of Zafirlukast Tablets 20 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition
Start: Dec 31, 2007
Completion: Jan 31, 2008
NCT01506076
Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fasting Conditions
NCT01131988
Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting Conditions
Start: Jan 31, 2008
Completion: Mar 31, 2008
NCT01132027
Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddys's Laboratories Limited Under Non-Fasting Conditions
NCT01506063
Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fed Conditions
NCT01375452
Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fasting Conditions
Start: Mar 31, 2008
Completion: May 31, 2008
NCT01053208
Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fasting Condition
Start: Apr 30, 2008
Completion: Apr 30, 2008
NCT01053338
Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fed Condition
NCT01372982
Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed Conditions
Completion: Jun 30, 2008
NCT01155947
Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting Conditions
Start: May 31, 2008
Completion: Jul 31, 2008
NCT01155960
Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Conditions
NCT02291341
Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed Condition
NCT02291367
Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition
NCT01621750
Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions
Start: Aug 31, 2008
Completion: Sep 30, 2008
NCT02322645
Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions
Completion: Oct 31, 2008
NCT01621763
Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions
Start: Sep 30, 2008
NCT01627886
Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition
NCT02322658
Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fed Conditions
NCT01270308
Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions
Start: Dec 31, 2008
Completion: Dec 31, 2008
NCT01513044
Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fasting Conditions
Start: Jan 31, 2009
Completion: Jan 31, 2009
NCT01513057
Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fed Conditions
Completion: Feb 28, 2009
NCT01645410
Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg of Dr. Reddy's Under Fed Conditions
Start: Mar 31, 2009
Completion: May 31, 2009
NCT01645384
Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting Conditions
Start: May 31, 2009
Completion: Jul 31, 2009
NCT01645423
Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fed Conditions
Start: Aug 31, 2009
Completion: Sep 30, 2009
NCT01504503
Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Condition
Start: Oct 31, 2009
Completion: Dec 31, 2009
NCT01504516
Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condition
NCT01627834
Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition
Completion: Nov 30, 2009
NCT01627847
Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition
NCT01674504
Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fasting Condition
Start: Jan 31, 2010
Completion: Jan 31, 2010
NCT02296749
Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition
Completion: Feb 28, 2010
NCT01671709
Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fasting Condition
Start: Feb 28, 2010
Completion: Mar 31, 2010
NCT01671722
Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fed Condition
NCT01674517
Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fed Condition
NCT02296762
Bioavailability Study of Sirolimus Tablets 2 mg Under Fed Condition
NCT01566487
Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condition
Start: Jun 30, 2010
Completion: Jun 30, 2010
NCT01645449
Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fasting Conditions
Completion: Aug 31, 2010
NCT01057537
UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events
Phase: Phase 3
Completion: Sep 30, 2012
NCT01888250
Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fasting Condition
Start: Aug 31, 2010
Completion: Sep 30, 2010
NCT01888263
Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Condition
NCT01888731
Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting Condition
NCT01888757
Lamotrigine Extended-Release Tablets 50 mg Under Fed Condition
Start: Sep 30, 2010
Completion: Oct 31, 2010
NCT01923259
Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed Condition
Start: Oct 31, 2010
Completion: Dec 31, 2010
NCT01923558
Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition
Completion: Nov 30, 2010
NCT02322632
Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions
Start: Nov 30, 2010
Completion: Feb 28, 2011
NCT01673997
Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting Conditions
Start: Dec 31, 2010
Completion: Jan 31, 2011
NCT01581775
Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's Under Fasting Conditions
Start: Jan 31, 2011
Completion: Mar 31, 2011
NCT01581788
Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditions
NCT01691456
Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fasting Condition
NCT01691469
Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fed Condition
NCT01694797
Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Condition
NCT01888718
Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting Condition
Start: Feb 28, 2011
NCT02922712
Evaluation of the Efficacy and Safety of Nise 100 mg in the Management of Osteoarthrosis (Gonarthrosis)
Phase: Phase 4
Start: Mar 31, 2011
Completion: Aug 31, 2013
NCT01336647
An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation
Phase: Phase 2
Start: Apr 30, 2011
Completion: Mar 31, 2012
NCT01888224
Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed Condition
Start: Jun 30, 2011
Completion: Jul 31, 2011
NCT01388816
A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels
Start: Jul 31, 2011
Completion: Jun 30, 2012
NCT02296723
Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition
Completion: Aug 31, 2011
NCT02297854
Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition
NCT01503398
Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions
Start: Aug 31, 2011
Completion: Sep 30, 2011
NCT01503424
Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study
NCT01402024
Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy
Completion: Jun 30, 2013
NCT02292069
Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition
Start: Sep 30, 2011
Completion: Oct 31, 2011
NCT02295046
Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition
Start: Oct 31, 2011
Completion: Nov 30, 2011
NCT01518699
Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers
Start: Jan 31, 2012
Completion: May 31, 2012
NCT01496352
DFA-02 in Patients Undergoing Colorectal Surgery
Phase: Phase 1/2
Start: Feb 29, 2012
NCT01559545
A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis
Start: Mar 31, 2012
Completion: Mar 31, 2013
NCT01674530
Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation
Start: Oct 31, 2012
Completion: Mar 31, 2014
NCT02322619
Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions
Start: Nov 30, 2012
Completion: Dec 31, 2012
NCT02922699
Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases
Start: Jan 31, 2013
NCT01907490
Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation
Start: Mar 31, 2013
Completion: Dec 31, 2013
NCT02638831
Ketorol Gel in Gonarthrosis and Low Back Pain
Completion: Nov 30, 2013
NCT02010333
A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
Start: Apr 30, 2013
Completion: Aug 31, 2014
NCT01871727
A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
Start: May 30, 2013
Completion: Dec 14, 2021
NCT02711943
Non Interventional Study of Levofloxacin in Chronic Prostatitis
Start: Jul 31, 2013
NCT01888367
Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery
Start: Oct 31, 2013
Completion: Feb 28, 2015
NCT02140073
Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity
Start: Dec 31, 2013
Completion: Jun 30, 2014
NCT02061813
Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion
Start: Jan 31, 2014
Completion: May 31, 2014
NCT02062073
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
NCT02060903
A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Start: Feb 28, 2014
NCT02062060
Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
NCT02205320
A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers
Completion: Sep 30, 2014
NCT02097485
Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Start: May 31, 2014
Completion: Oct 31, 2014
NCT02173301
A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis
Start: Jun 30, 2014
Completion: Aug 31, 2015
NCT02260544
Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
Start: Jul 31, 2014
NCT02279082
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Start: Sep 30, 2014
Completion: Mar 31, 2016
NCT02712502
Levofloxacin in Bacterial Rhinosinussitis
Completion: Dec 31, 2014
NCT02296775
Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis
Start: Nov 30, 2014
Completion: Oct 5, 2017
NCT03706300
Bioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg Under Fasting Conditions
Start: Dec 31, 2014
Completion: Jan 31, 2015
NCT02865161
Amtolmetin Gaucil in Knee Osteoarthritis
Start: Feb 28, 2015
Completion: Dec 31, 2015
NCT02472418
Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches
Start: Jun 5, 2015
Completion: May 5, 2016
NCT03051685
Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults
Start: Jul 20, 2015
Completion: Nov 10, 2015
NCT02301962
Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer
Start: Jul 28, 2015
Completion: Jan 31, 2022
NCT02569853
DFN-11 Injection in Episodic Migraine With or Without Aura
Start: Sep 21, 2015
Completion: Feb 26, 2018
NCT02571049
Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine
Start: Sep 30, 2015
Completion: May 31, 2016
NCT02572986
A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies
Completion: Aug 31, 2016
NCT02583425
Pilot Study of DFN-11 Injection in Medication Overuse Headache
Completion: Nov 30, 2016
NCT03696329
Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fasting Conditions
Start: Oct 31, 2015
Completion: Nov 30, 2015
NCT03702855
Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fed Conditions
Start: Dec 31, 2015
NCT02798419
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Start: Jan 31, 2016
NCT02828241
A Study to Assess the Efficacy, Safety and Tolerability of DFD-04
Start: Jul 31, 2016
Completion: Nov 30, 2017
NCT03478436
Pharmacokinetics of Doxycycline in Skin of Healthy Volunteers
Completion: Oct 25, 2016
NCT03009019
Efficacy, Tolerability, and Safety of DFN-15
Start: Dec 31, 2016
Completion: May 31, 2019
NCT03116698
A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period
Phase: Phase 2/3
Start: Feb 14, 2017
Completion: Jul 5, 2018
NCT03160807
Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections
Start: Apr 15, 2017
Completion: Mar 31, 2018
NCT03282838
Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects
Start: Jun 9, 2017
Completion: Jan 12, 2018
NCT03292640
A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks
Start: Jul 6, 2017
Completion: May 14, 2018
NCT03290027
A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris
Start: Jul 31, 2017
Completion: Apr 19, 2018
NCT03341910
A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris
Start: Aug 21, 2017
Completion: May 18, 2018
NCT03340961
A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules
Start: Oct 1, 2017
Completion: Mar 31, 2019
NCT03599193
A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris
Start: Oct 4, 2017
Completion: Apr 30, 2018
NCT03421197
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
Start: Jan 25, 2018
Completion: Mar 30, 2020
NCT03472378
Can DFN-15 Terminate Migraine With Allodynia?
Start: May 9, 2018
Completion: Apr 12, 2019
NCT03554772
Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15
Start: Jun 19, 2018
Completion: Aug 20, 2018
NCT03976102
Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma
Start: May 15, 2019
Completion: Feb 27, 2023
NCT04268771
A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products
Start: Apr 8, 2020
Completion: Apr 20, 2022
NCT04529499
Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients
Start: Aug 22, 2020
Completion: Jan 27, 2021
NCT04640233
Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection
Start: Nov 30, 2020
Completion: Sep 30, 2021
NCT05140655
Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-
Start: Apr 19, 2021
Completion: Aug 19, 2022
NCT04885829
Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers
Start: May 31, 2021
Completion: May 4, 2023
NCT05296629
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
Start: Mar 14, 2022
Completion: Jun 30, 2023
NCT05343455
A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)
Start: Mar 29, 2022
NCT05452785
A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects
Start: May 7, 2022
Completion: May 25, 2022
NCT05200559
T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors
Start: Sep 30, 2022
Completion: Dec 31, 2027
NCT05597462
Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks
Completion: May 30, 2023
NCT06126042
Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route
Start: Oct 3, 2023
Completion: Jul 31, 2024
NCT06193187
A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
Start: Jan 31, 2024
Completion: Aug 31, 2024
Loading map...